Rashidul Haque, & Sultana Rajia. (2023). AMP-kinase is the Main Target of Metformin in Regulating Type 2 Diabetes. Research Highlights in Disease and Health Research Vol. 2, 83–95. https://doi.org/10.9734/bpi/rhdhr/v2/9366F